Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
- PMID: 28109828
- PMCID: PMC5474429
- DOI: 10.1016/j.ebiom.2017.01.012
Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
Comment on
-
Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.EBioMedicine. 2017 Feb;15:62-72. doi: 10.1016/j.ebiom.2016.12.003. Epub 2016 Dec 9. EBioMedicine. 2017. PMID: 27993630 Free PMC article.
References
-
- Kim H., Abd Elmageed Z.Y., Ju J., Naura A.S., Abdel-Mageed A.B., Varughese S., Paul D., Alahari S., Catling A., Kim J.G., Boulares A.H. PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth. Mol. Med. 2013;19:253–262. - PMC - PubMed
-
- Kocher O., Comella N., Gilchrist A., Pal R., Tognazzi K., Brown L.F., Knoll J.H. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab. Investig. 1999;79(9):1161–1170. - PubMed
-
- Kocher O., Yesilaltay A., Cirovic C., Pal R., Rigotti A., Krieger M. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J. Biol. Chem. 2003;278(52):52820–52825. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
